REGENXBIO
RGNX
$28.07
Share price
1.92%
Change (1 day)
-26.98%
Change (1 year)
Categories
Market capitalization of REGENXBIO (RGNX)
Market cap: $1.21 Billion
As of July 2022 REGENXBIO has a market cap of $1.21 Billion. This makes REGENXBIO the world's 4113th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of REGENXBIO from 2015 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.21 B | -13.43% |
| 2021 | $1.39 B | -17.73% |
| 2020 | $1.69 B | 12.16% |
| 2019 | $1.51 B | 0.02% |
| 2018 | $1.51 B | 46.32% |
| 2017 | $1.03 B | 110.86% |
| 2016 | $0.49 B | 12.44% |
| 2015 | $0.43 B |
End of Day market cap according to different sources
On Jul 6th, 2022 the market cap of REGENXBIO was reported to be:
$1.17 Billion
$1.18 Billion
$1.18 Billion
$1.18 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -83.16% | 🇺🇸 USA |